Correlation Between Visa and Century Therapeutics
Can any of the company-specific risk be diversified away by investing in both Visa and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Century Therapeutics, you can compare the effects of market volatilities on Visa and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Century Therapeutics.
Diversification Opportunities for Visa and Century Therapeutics
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Visa and Century is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Visa i.e., Visa and Century Therapeutics go up and down completely randomly.
Pair Corralation between Visa and Century Therapeutics
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.21 times more return on investment than Century Therapeutics. However, Visa Class A is 4.68 times less risky than Century Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Century Therapeutics is currently generating about -0.16 per unit of risk. If you would invest 31,488 in Visa Class A on October 20, 2024 and sell it today you would earn a total of 474.00 from holding Visa Class A or generate 1.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Visa Class A vs. Century Therapeutics
Performance |
| Timeline |
| Visa Class A |
| Century Therapeutics |
Visa and Century Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Century Therapeutics
The main advantage of trading using opposite Visa and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |